Disorders with Malignant Potential



Disorders with Malignant Potential


Lawrence Eichenfield M.D.


Clinical Pearls

(LE)




Basal Cell Nevus Syndrome


Synonym

Nevoid basal cell carcinoma syndrome

Gorlin syndrome


Inheritance

Autosomal dominant; PTCH1 (PATCHED1) gene on 9q22-31


Prenatal Diagnosis

DNA mutation analysis


Incidence

Approximately 1:60,000; M=F


Age at Presentation

Birth (bossing, skeletal anomalies); childhood (jaw cysts, basal cell carcinoma)


Pathogenesis

Mutations in PTCH1, a tumor suppressor gene encoding the sonic hedgehog transmembrane receptor protein; receptor interacts with signaling proteins important for controlling cell fate, patterning, and growth


Key Features


Skin

Basal cell carcinomas (BCCs)—multiple, skin-colored to tan, dome-shaped papules on face, neck, trunk

Palmoplantar pits—2- to 3-mm erythematous pits, rarely develop into BCCs; milium, epidermoid cysts


Musculoskeletal

Jaw cysts (odontogenic keratocysts)—secondary pain, swelling, drainage, increased in molar and premolar areas in maxilla, usually multiple, lining with malignant potential

Frontal bossing, bifid ribs, vertebral fusion, kyphoscoliosis


Central Nervous System

Calcification of falx cerebri, agenesis of corpus callosum, medulloblastoma, mental retardation (less common)


Eyes

Hypertelorism, congenital blindness, cataracts, colobomas, strabismus


Genitourinary

Ovarian fibromas, fibrosarcoma


Differential Diagnosis

Bazex syndrome

Unilateral linear nevoid basal cell carcinomas

Melanocytic nevi

Rombo syndrome

Xeroderma pigmentosa (XP) (p. 174)


Laboratory Data

Skin biopsy

Skeletal surveys of skull, maxilla, mandible, ribs, vertebrae



Management

Referral to dentist/oral surgeon

Referral to dermatologist/Moh’s surgeon—surgical excision, electrodesiccation and curettage with/without general anesthesia, topical 5-fluorouracil, imiquimod; frequent cutaneous examinations

Oral retinoids—suppression of new BCCs

Avoid radiotherapy/x-rays—induces new BCCs

Sun avoidance, broad-spectrum sunscreen, protective clothing

Referral to orthopedist, neurologist, ophthalmologist


Prognosis

Normal life span if BCCs treated early on and no other malignancies develop; close surveillance with physician throughout life; disfiguring scars may create psychosocial problems








5.1. Pigmented facial basal cell carcinomas with post-surgical scars and glabellar graft. (5)






5.2. Multiple tan-brown basal cell carcinomas on patient’s back. (5)






5.3. Large jaw cysts in maxilla and mandible. (5)






image




Xeroderma Pigmentosum


Inheritance

Autosomal recessive

XPA gene encodes DNA damage binding protein 1 (DDB1) gene on 9q22

XPB gene encodes excision-repair cross-complementing 3 (ERCC3) gene on 2q21

XPC gene encodes endonuclease on 3p25

XPD gene encodes ERCC2 on 19q13

XPE gene encodes DDB2 on 11p12

XPF gene encodes ERCC4 on 16p13

XPG gene encodes endonuclease on 13q33

XPV (Variant) gene encodes polymerase η on 6p21


Prenatal Diagnosis

DNA analysis

UDS (unscheduled DNA synthesis) assay on cultured amniotic fluid cells


Incidence

1:1,000,000 in the United States; 1:40,000 in Japan; M=F

XPA, C, and V comprise 75% of all patients

XPA—most common form in Japan, over 90% with identical single base substitution mutation; skin with mild-severe neurologic manifestations

XPB—rare in the United States; skin and neurologic; association with Cockayne syndrome, trichothiodystrophy

XPC—most common form in the United States, rare in Japan; skin without neurologic manifestations

XPD—moderate frequency; association with trichothiodystrophy and XP-Cockayne complex, skin and neurologic manifestations

XPE—rare; mild skin without neurologic manifestations

XPF—moderate rare; most seen in Japan; skin without neurologic manifestations

XPG—extremely rare; association with Cockayne, skin with Cockayne-like neurologic manifestations

XPV—approximately 30% of all cases; United States, Europe, Japan; mild-severe skin without neurologic manifestations


Age of Presentation

First few years of life


Pathogenesis

Mutations in genes encoding DNA repair enzymes (DNA helicase, endonuclease, or DNA damage-binding protein) leads to defective DNA excision repair upon exposure to ultraviolet radiation; defective postreplication repair in XPV group

Complementation groups (total of 8), based on correction of reduced post-UV UDS after fusion of skin fibroblasts from two different patients, have distinct clinical characteristics, frequency and distribution


Key Features


Skin (severity may vary with different complementation groups)


Infancy

Acute sun sensitivity with sunburn-like reaction (erythema, inflammation, bullae)


First Years of Life

Childhood/adolescence (listed in order of appearance)—pigmented macules, achromic macules, and telangiectasias in photodistribution; dry, scaly, atrophic, with narrowing of mouth and nares; actinic keratoses, keratoacanthomas; 1,000-fold increased risk for basal cell carcinoma, squamous cell carcinoma, malignant melanoma



Eyes

Progressive symptomatology with photophobia, conjunctivitis, telangiectasia and pigmentation of lid and conjunctiva; ectropion, corneal vascularization, opacification; benign lid papillomas; BCC, malignant melanoma


Neurologic (20% of cases—most in XPA and XPD)

Progressive neurologic degeneration with mental retardation, sensorineural deafness; with/without microcephaly, hyporeflexia, spasticity, ataxia


Differential Diagnosis


Infancy/Early Childhood

Erythropoietic protoporphyria (p. 224)

Congenital erythropoietic porphyria (p. 226)

Bloom syndrome (p. 234)

Cockayne syndrome (p. 242)

Hartnup disease (p. 250)

Rothmund-Thomson syndrome (p. 238)


Laboratory Data

DNA analysis

UDS assay from cultured skin fibroblasts


Management

Referral to dermatologist—sun avoidance/limit outdoor activity to early morning, late afternoon and night; photoprotect with physical block sunscreen, long-sleeve, long pants, frogskin clothing, wide-brimmed hat, UV-blocking glasses with side shields, long hair styles

Dermatologic cancer screening every 3 months with weekly examination by informed parent

Removal of cutaneous neoplasms, cryotherapy, 5-fluorouracil, imiquimod Isotretinoin—prevention of new skin cancers

Referral to ophthalmologist—corneal protection with methylcellulose drops, soft contact lens; corneal transplantation, regular cancer screening

Referral to neurologist if symptomatic

Referral to XP support group


Prognosis

Early diagnosis with UV protection and close malignancy surveillance will prevent skin cancers; otherwise premature death at early age; UV exposure prior to diagnosis and protection may induce neoplasm; neurologic symptoms are progressive and unaffected by UV protection; severe psychosocial impact








5.4. Photodistributed bullae, erythema, and inflammation in girl with XP. Note sharp cut-off of eruption on exposed neck. (66)






5.5. Destructive cutaneous carcinomas and squamous cell carcinoma of the tongue in this unfortunate terminal boy. (20)






5.6. Iris melanoma and blood obliterate the anterior chamber of the eye. (67)






image




Muir-Torre Syndrome


Synonym

Torre syndrome

Torre-Muir syndrome


Inheritance

Autosomal dominant; MSH1 and MSH2 genes on 3p21 and 2p22-21, respectively


Prenatal Diagnosis

DNA analysis


Incidence

At least 65 cases reported; M=F


Age of Presentation

Fifth to sixth decade of life (internal malignancies usually precede cutaneous lesions)


Pathogenesis

Mutations in MSH2 (most common) and MSH1, DNA mismatch repair genes, produces phenotype; syndrome is linked to the Lynch II cancer family syndrome


Key Features


Skin

Multiple sebaceous tumors: adenomas (most common), carcinomas, hyperplasias, epitheliomas, basal cell carcinoma with sebaceous differentiation Keratoacanthomas


Neoplasms

Adenocarcinoma of the colon (most common), other gastrointestinal tract, genitourinary tract, lung, breast, and hematologic malignancies described


Differential Diagnosis

Cowden syndrome (p. 188)

Gardner syndrome (p. 184)


Laboratory Data

Skin biopsy

Endoscopy/gastrointestinal x-ray


Management

Close follow-up by internist screening for malignancy

Referral to dermatologist

Referral to gastroenterologist


Prognosis

Malignancies usually low-grade with good prognosis; may have normal life span with close surveillance and early detection of malignancy







image







5.7. Multiple sebaceous hyperplasia and sebaceous adenomas on patient’s forehead. (68)






5.8. Sebaceous carcinoma of upper eyelid. (69)



Dyskeratosis Congenita


Synonym

Zinsser-Engman-Cole syndrome


Inheritance

X-linked recessive (most common); dyskerin (DKC1) gene on Xq28; autosomal dominant and recessive patterns have been described; telomerase RNA component (TERC) gene on 3q21-q28 in autosomal dominant cases


Prenatal Diagnosis

DNA analysis


Incidence

Over 100 cases reported; M:F=10:1


Age at Presentation

First decade of life (cutaneous, nail, mucosal changes)


Pathogenesis

Mutation in the DKC1 gene encoding the dyskerin protein has untoward effects on RNA nucleolar function and RNA telomerase activity with subsequent problems in cell proliferation in blood and epithelium; TERC gene mutations responsible for the RNA component of telomerase, has been implicated in autosomal dominant cases


Key Features


Skin

Reticulated gray-brown hyperpigmentation on neck, face, trunk, upper thighs; atrophy, hypopigmentation, and telangiectasias within pigmentation Palmoplantar hyperkeratosis, hyperhidrosis, friction bullae, acrocyanosis


Hair

Thinning alopecia on scalp, eyebrows, eyelashes


Nails

Dystrophic with longitudinal ridges, pterygium; atrophic, or absent


Mouth

Premalignant leukoplakia of the tongue, buccal mucosa, pharynx; dental caries with early loss of teeth


Mucous Membranes

Premalignant leukoplakia of any mucosal surface


Hematologic

Fanconi’s type pancytopenia with secondary infection, hemorrhage


Eyes

Blepharitis, conjunctivitis, lacrimal duct obstruction with epiphora, ectropion


Central Nervous System

Mild to moderate mental retardation (50%)


Differential Diagnosis

Fanconi syndrome

Pachyonychia congenita (p. 294)

Rothmund-Thomson syndrome (p. 238)

Chronic graft vs. host disease



Laboratory Data

Mucosal biopsy

Bone marrow biopsy

DNA analysis


Management

Referral to hematologist/oncologist—bone marrow transplantation, transfusions, oral retinoids

Referral to dermatologist, otolaryngologist, gastroenterologist, ophthalmologist

Counsel against excessive sun exposure, smoking


Prognosis

Death usually in 20s to 30s secondary to malignancy (usually squamous cell carcinoma), gastrointestinal hemorrhage, or opportunistic infection








5.9. Poikilodermatous changes in the axilla extending on to arm. (1)






5.10. Dystrophic and absent nails. (1)






5.11. Premalignant leukoplakia of the buccal mucosa. (70)






image




Gardner Syndrome


Inheritance

Autosomal dominant; adenomatous polyposis coli (APC) gene on 5q21-22


Prenatal Diagnosis

DNA analysis


Incidence

Approximately 1:14,000; M=F


Age at Presentation

Infancy to early childhood (bone, skin lesions); second to fourth decade (gastrointestinal lesions)


Pathogenesis

Mutations in APC, a tumor suppressor gene that regulates B-catenin, an adherens junction protein controlling cell growth and early embryonic axis formation, promotes tumor formation; high dietary fat may play a role in patients with the genetic defect


Key Features


Skin

Epidermoid cysts—increased on head and neck; may have unusual location on toe, scalp, shin

Fibromas


Musculoskeletal

Osteomas—maxilla, mandible, other skull bones; small, multiple


Gastrointestinal

Polyposis with high predisposition to malignant adenocarcinoma; most common in colon/rectum

Desmoid tumors—postabdominal surgery; uteral or intestinal obstruction


Eyes

Congenital hypertrophy of retinal pigment epithelium (CHRPE)—congenital marker for diagnosis


Teeth

Odontomas, supernumerary teeth

Jun 25, 2016 | Posted by in Dermatology | Comments Off on Disorders with Malignant Potential

Full access? Get Clinical Tree

Get Clinical Tree app for offline access